Shared publicly  - 
Gammagard, an intravenous immune therapy drug, is being hailed in the media as a solution for stabilizing Alzheimer's disease after early stages of testing. Take a look 'Behind the Headlines' to find out why it's far too early to know the message.
kamila anna folkestad's profile photoSanny Estrada's profile photoPuck Smith's profile photoNuno Tavares's profile photo
Promising cure for memory lose of aging brain?
 I hope phase III trials will be successful, as Professor Clive Ballard, Director of Research at the Alzheimer’s Society postulates yet ohh 10 years from now to wait for the drug to be released seems to be such a long time, why does it take so long....
Add a comment...